US FDA CDER, CBER Staff Say Pandemic Had Negative Effect On Hiring, Retention
Executive Summary
Human resource managers also worried that since universal teleworking was valued by employees, a return to pre-pandemic conditions could cause a mass exodus.
You may also be interested in...
US FDA User Fee Staffing: The Objective Capacity Planning Adjuster Often Needs Subjective Review
The FDA has overruled the results from its own formula intended to match resource levels with workload every time except once.
‘Opioids’ Is Missing From The US FDA’s Overdose Prevention Framework Title On Purpose
Unlike prior plans, the FDA’s new substance abuse framework is intended to deal with stimulant and benzodiazepine use disorders, in addition to opioid abuse.
Operation Warp Speed For Rare Diseases? US FDA Is Considering Pilot Programs
CBER director Peter Marks says the FDA may evaluate giving gene therapy products the ‘degree of responsiveness’ that COVID-19 vaccines received. In a discussion of the pandemic's effects on staff retention, CDER director Patrizia Cavazzoni says attrition rates are back to historical levels.